Learn More
Description
- Molecular accuracy without the wait - Improve clinical outcomes by administering immediate treatment in just 30 minutes.
- Accessible molecular testing - Breakthrough platform designed to eliminate cost-barriers.
- Reduce repeat testing - No need for serial or confirmation testing when nasal specimen is used.
- Alleviates testing restrictions - Indicated for symptomatic and asymptomatic testing, allowing for screening prior to medical procedures.
- Simple workflow - Can be performed in any point-of-care setting, with minimal training required.
- Convenient sampling - The only test with dual-sample types, allowing you to provide the best patient experience possible.
- Exceptional Support - Experienced support teams and online training modules to help streamline your testing implementation.
Specifications
Specifications
| CE Marker | No |
| Clia Complexity | Waived (FDA, EUA) |
| Detectable Analytes | COVID-19 |
| DoA Calibrators | No |
| Type | COVID-19 Test |
| Disposable | Reusable |
| For Use With (Application) | Point-of-Care Testing |
| Includes | 25 Tests |
| Quantity | 25 Tests/Kit |
| Sterility | Sterile |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.